A dynamical model of human immune response to influenza A virus infection

Journal of Theoretical Biology

Volumn 246, Issue 1, 2007, Pages 70-86

  Hancioglu, Baris ^a   Swigon, David ^a,b   Clermont, Gilles ^a,b,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CIRM (Center for Inflammation and Regenerative Modeling)   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Antigenic distance; Human immune response; Immunology; Influenza; Mathematical modeling

Indexed keywords

IMMUNE RESPONSE; IMMUNITY; INFLUENZA; NUMERICAL MODEL; RESPIRATORY DISEASE; VIRAL DISEASE; VIRUS;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; ARTICLE; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; HUMAN; IMMUNE RESPONSE; INFECTION CONTROL; INFLUENZA VIRUS A; INNATE IMMUNITY; MATHEMATICAL MODEL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; VIRUS INFECTION; VIRUS LOAD; VIRUS VIRULENCE;

ANTIBODIES, VIRAL; ANTIGEN-PRESENTING CELLS; COMPUTER SIMULATION; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS; INFLUENZA, HUMAN; INTERFERONS; MODELS, IMMUNOLOGICAL; RECURRENCE; RESPIRATORY MUCOSA; T-LYMPHOCYTES; VIRAL LOAD;

INFLUENZA A VIRUS;

EID: 34147167183     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2006.12.015     Document Type: Article

References (49)

1. Ada G.L., and Jones P.D. The immune response to influenza infection. Curr. Top. Microbiol. Immunol. 128 (1986) 1-54
2. Akira S., Takeda K., and Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2 (2001) 675-680
3. Asquith B., and Bangham C.R. An introduction to lymphocyte and viral dynamics: the power and limitations of mathematical analysis. Proc. Biol. Sci. 270 (2003) 1651-1657
4. Bocharov G.A., and Romanyukha A.A. Mathematical model of antiviral immune response. III. Influenza A virus infection. J. Theor. Biol. 167 (1994) 323-360
5. Chow C.C., Clermont G., Kumar R., Lagoa C., Tawadrous Z., Gallo D., Betten B., Bartels J., Constantine G., Fink M.P., Billiar T.R., and Vodovotz Y. The acute inflammatory response in diverse shock states. Shock 24 (2005) 74-84
6. Clermont G., Bartels J., Kumar R., Constantine G., Vodovotz Y., and Chow C. In silico design of clinical trials: a method coming of age. Crit. Care Med. 32 (2004) 2061-2070
7. Couch R.B., and Kasel J.A. Immunity to influenza in man. Annu. Rev. Microbiol. 37 (1983) 529-549
8. Epstein S.L., Lo C.Y., Misplon J.A., and Bennink J.R. Mechanism of protective immunity against influenza virus infection in mice without antibodies. J. Immunol. 160 (1998) 322-327
9. Hayden F.G., Fritz R., Lobo M.C., Alvord W., Strober W., and Straus S.E. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. J. Clin. Invest. 101 (1998) 643-649
10. Iwasaki T., and Nozima T. Defense mechanisms against primary influenza virus infection in mice. I. The roles of interferon and neutralizing antibodies and thymus dependence of interferon and antibody production. J. Immunol. 118 (1977) 256-263
11. Johansson B.E., Bucher D.J., and Kilbourne E.D. Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection. J. Virol. 63 (1989) 1239-1246
12. Joklik W.K. Interferons. In: Fields B.N., Knipe R.M., Melnick J.L., Chanok M.S., Riozman B., and Shope R.E. (Eds). Virology (1985), Raven Press, New York 281-307
13. Julkunen I., Melen K., Nyqvist M., Pirhonen J., Sareneva T., and Matikainen S. Inflammatory responses in influenza A virus infection. Vaccine 19 Suppl. 1 (2000) S32-S37
14. Keenan K.P., Combs J.W., and McDowell E.M. Regeneration of hamster tracheal epithelium after mechanical injury. I. Focal lesions: quantitative morphologic study of cell proliferation. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 41 (1982) 193-214
15. Kuiken T., Holmes E.C., McCauley J., Rimmelzwaan G.F., Williams C.S., and Grenfell B.T. Host species barriers to influenza virus infections. Science 312 (2006) 394-397
16. Lamb R.K.R. Orthomyxoviridae: The Viruses and their Replication (1996), Lippincott-Raven Publishers, Philadelphia pp. 1353-1396
17. Liew F.Y., Russell S.M., Appleyard G., Brand C.M., and Beale J. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur. J. Immunol. 14 (1984) 350-356
18. Marchuk G.I., and Berbentsova E.P. [Results using a quantitative method for evaluating the severity and dynamics of acute pneumonia, chronic bronchitis and bronchial asthma]. Ter. Arkh. 58 (1986) 63-70
19. Marchuk G.I., Petrov R.V., Romanyukha A.A., and Bocharov G.A. Mathematical model of antiviral immune response. I. Data analysis, generalized picture construction and parameters evaluation for hepatitis B. J. Theor. Biol. 151 (1991) 1-40
20. Meltzer M.I., Cox N.J., and Fukuda K. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg. Infect. Dis. 5 (1999) 659-671
21. Mohler L., Flockerzi D., Sann H., and Reichl U. Mathematical model of influenza A virus production in large-scale microcarrier culture. Biotechnol. Bioeng. 90 (2005) 46-58
22. Murphy B.R., and Clements M.L. The systemic and mucosal immune response of humans to influenza A virus. Curr. Top. Microbiol. Immunol. 146 (1989) 107-116
23. Neumann A.U., Lam N.P., Dahari H., Gretch D.R., Wiley T.E., Layden T.J., and Perelson A.S. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282 (1998) 103-107
24. Nguyen H.H., Boyaka P.N., Moldoveanu Z., Novak M.J., Kiyono H., McGhee J.R., and Mestecky J. Influenza virus-infected epithelial cells present viral antigens to antigen-specific CD8+ cytotoxic T lymphocytes. J. Virol. 72 (1998) 4534-4536
25. Nicholson K.G., Webster A.G., and Hay A.J. Textbook of Influenza (1998), Blackwell Science, Oxford
26. Nowak M.A., and Bangham C.R. Population dynamics of immune responses to persistent viruses. Science 272 (1996) 74-79
27. Nowak M.A., and May R. Virus Dynamics: The Mathematical Foundations of Immunology and Virology (2000), Oxford University Press, Oxford
28. Perelson A.S. Modelling viral and immune system dynamics. Nat. Rev. Immunol. 2 (2002) 28-36
29. Perelson A.S., Kirschner D.E., and De B.R. Dynamics of HIV infection of CD4+ T cells. Math. Biosci. 114 (1993) 81-125
30. Perelson A.S., Neumann A.U., Markowitz M., Leonard J.M., and Ho D.D. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271 (1996) 1582-1586
31. Price G.E., Gaszewska-Mastarlarz A., and Moskophidis D. The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice. J. Virol. 74 (2000) 3996-4003
32. Ronni T., Sareneva T., Pirhonen J., and Julkunen I. Activation of IFN-alpha, IFN-gamma, MxA, and IFN regulatory factor 1 genes in influenza A virus-infected human peripheral blood mononuclear cells. J. Immunol. 154 (1995) 2764-2774
33. Sareneva T., Matikainen S., Kurimoto M., and Julkunen I. Influenza A virus-induced IFN-alpha/beta and IL-18 synergistically enhance IFN-gamma gene expression in human T cells. J. Immunol. 160 (1998) 6032-6038
34. Scherle P.A., Palladino G., and Gerhard W. Mice can recover from pulmonary influenza virus infection in the absence of class I-restricted cytotoxic T cells. J. Immunol. 148 (1992) 212-217
35. Shinya K., Ebina M., Yamada S., Ono M., Kasai N., and Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature 440 (2006) 435-436
36. Smith D.J., Forrest S., Ackley D.H., and Perelson A.S. Variable efficacy of repeated annual influenza vaccination. Proc. Natl. Acad. Sci. USA 96 (1999) 14001-14006
37. Stark G.R., Kerr I.M., Williams B.R., Silverman R.H., and Schreiber R.D. How cells respond to interferons. Annu. Rev. Biochem. 67 (1998) 227-264
38. Tamura S., and Kurata T. Defense mechanisms against influenza virus infection in the respiratory tract mucosa. Jpn. J. Infect. Dis. 57 (2004) 236-247
39. Tamura S., Iwasaki T., Thompson A.H., Asanuma H., Chen Z., Suzuki Y., Aizawa C., and Kurata T. Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infection. J. Gen. Virol. 79 Pt 2 (1998) 291-299
40. Tamura S., Tanimoto T., and Kurata T. Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines. Jpn. J. Infect. Dis. 58 (2005) 195-207
41. Taubenberger J.K., and Morens D.M. 1918 Influenza: the mother of all pandemics. Emerg. Infect. Dis. 12 (2006) 15-22
42. Tulp A., Verwoerd D., Dobberstein B., Ploegh H.L., and Pieters J. Isolation and characterization of the intracellular MHC class II compartment. Nature 369 (1994) 120-126
43. Webster R.G., Peiris M., Chen H., and Guan Y. H5N1 outbreaks and enzootic influenza. Emerg. Infect. Dis. 12 (2006) 3-8
44. Wohlfart C. Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms. J. Virol. 62 (1988) 2321-2328
45. Wyde P.R., Wilson M.R., and Cate T.R. Interferon production by leukocytes infiltrating the lungs of mice during primary influenza virus infection. Infect. Immun. 38 (1982) 1249-1255
46. Yetter R.A., Lehrer S., Ramphal R., and Small Jr. P.A. Outcome of influenza infection: effect of site of initial infection and heterotypic immunity. Infect. Immun. 29 (1980) 654-662
47. Yewdell J.W., Bennink J.R., Smith G.L., and Moss B. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc. Natl. Acad. Sci. USA 82 (1985) 1785-1789
48. Yoshikawa T., Matsuo K., Matsuo K., Suzuki Y., Nomoto A., Tamura S., Kurata T., and Sata T. Total viral genome copies and virus-Ig complexes after infection with influenza virus in the nasal secretions of immunized mice. J. Gen. Virol. 85 (2004) 2339-2346
49. Zdanov V.M., and Bukrinskaja A.G. Myxoviruses Reproduction (1969), Medicina, Moscow, Russia